HOGAN LOVELLS US LLP

Lobbying for LEGEND BIOTECH CORPORATION · Biotechnology company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $90,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.